Fatiha Tabet

4.0k total citations
40 papers, 3.1k citations indexed

About

Fatiha Tabet is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fatiha Tabet has authored 40 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 13 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fatiha Tabet's work include Lipoproteins and Cardiovascular Health (9 papers), MicroRNA in disease regulation (8 papers) and Nitric Oxide and Endothelin Effects (7 papers). Fatiha Tabet is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), MicroRNA in disease regulation (8 papers) and Nitric Oxide and Endothelin Effects (7 papers). Fatiha Tabet collaborates with scholars based in Australia, United States and Canada. Fatiha Tabet's co-authors include Rhian M. Touyz, Ernesto L. Schiffrin, Kerry‐Anne Rye, Philip J. Barter, Guoying Yao, Gilles Lambert, Kerry-Anne Rye, Kasey C. Vickers, Mark T. Quinn and Patrick J. Pagano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of the American College of Cardiology.

In The Last Decade

Fatiha Tabet

40 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatiha Tabet Australia 25 1.2k 875 789 778 737 40 3.1k
Saša Frank Austria 34 1.1k 0.9× 1.0k 1.1× 611 0.8× 451 0.6× 393 0.5× 98 3.1k
Anna C. Calkin Australia 28 1.5k 1.3× 1.0k 1.2× 736 0.9× 410 0.5× 491 0.7× 59 3.6k
Sanja Levak‐Frank Austria 27 1.1k 0.9× 734 0.8× 537 0.7× 284 0.4× 762 1.0× 41 2.7k
I. George Fantus Canada 36 2.2k 1.8× 676 0.8× 925 1.2× 321 0.4× 903 1.2× 66 4.5k
Radko Komers United States 33 1.2k 1.0× 366 0.4× 666 0.8× 407 0.5× 689 0.9× 102 3.6k
Giulio Ceolotto Italy 33 1.3k 1.1× 566 0.6× 736 0.9× 308 0.4× 649 0.9× 105 3.2k
Josep Julve Spain 27 743 0.6× 1.0k 1.2× 784 1.0× 368 0.5× 331 0.4× 133 2.4k
Toshiro Sugimoto Japan 41 2.1k 1.7× 610 0.7× 907 1.1× 360 0.5× 843 1.1× 100 5.3k
Graciela Castro France 31 1.2k 1.0× 1.9k 2.2× 1.4k 1.7× 637 0.8× 386 0.5× 56 3.4k
Masao Takemoto Japan 15 889 0.7× 974 1.1× 315 0.4× 344 0.4× 825 1.1× 66 3.4k

Countries citing papers authored by Fatiha Tabet

Since Specialization
Citations

This map shows the geographic impact of Fatiha Tabet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatiha Tabet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatiha Tabet more than expected).

Fields of papers citing papers by Fatiha Tabet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatiha Tabet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatiha Tabet. The network helps show where Fatiha Tabet may publish in the future.

Co-authorship network of co-authors of Fatiha Tabet

This figure shows the co-authorship network connecting the top 25 collaborators of Fatiha Tabet. A scholar is included among the top collaborators of Fatiha Tabet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatiha Tabet. Fatiha Tabet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Margaret J., Matthew Allison, Michael Y. Tsai, et al.. (2020). Lipoprotein (a) and the risk of elevated depressive symptoms: The Multi-Ethnic Study of Atherosclerosis. Journal of Psychiatric Research. 133. 119–124. 6 indexed citations
2.
Ho, Jan Hoong, Kwok Leung Ong, Luisa Torres, et al.. (2020). High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity. Journal of Lipid Research. 62. 100043–100043. 15 indexed citations
3.
Adam, Safwaan, Akheel A. Syed, Basil J. Ammori, et al.. (2020). Changes in the effect of HDL on pancreatic beta-cell insulin secretion following metabolic surgery. Atherosclerosis. 315. e150–e151. 1 indexed citations
4.
Torres, Luisa, Wanying Zhu, Mili Patel, et al.. (2019). High-density lipoproteins induce miR-223–3p biogenesis and export from myeloid cells: Role of scavenger receptor BI-mediated lipid transfer. Atherosclerosis. 286. 20–29. 24 indexed citations
5.
Tabet, Fatiha, Blake J. Cochran, Luisa Torres, et al.. (2019). Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle. Scientific Reports. 9(1). 1350–1350. 51 indexed citations
6.
Torres, Luisa, Jennifer Barraclough, Gonzalo J. Martínez, et al.. (2018). Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease. International Journal of Cardiology. 253. 138–144. 17 indexed citations
7.
Arsenault, Benoît J., Francine Petrides, Fatiha Tabet, et al.. (2017). Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk. Journal of clinical lipidology. 12(1). 130–136. 46 indexed citations
8.
Tabet, Fatiha, Luisa Torres, Kwok Leung Ong, et al.. (2016). High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males. PLoS ONE. 11(3). e0151061–e0151061. 40 indexed citations
9.
Wiese, Carrie B., Cynthia L. Toth, Fatiha Tabet, et al.. (2014). Abstract 3: HDL-MicroRNA-92a and Interleukin-33 Axis Underlies Endothelial Dysfunction Associated With Atherosclerosis and Chronic Kidney Disease. Arteriosclerosis Thrombosis and Vascular Biology. 34(suppl_1). 1 indexed citations
10.
Lambert, Gilles, Francine Petrides, Mathias Chatelais, et al.. (2014). Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects. Journal of the American College of Cardiology. 63(22). 2365–2373. 41 indexed citations
11.
Tabet, Fatiha, Kasey C. Vickers, Luisa Torres, et al.. (2014). HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nature Communications. 5(1). 3292–3292. 335 indexed citations
12.
Briones, Ana M., Fatiha Tabet, Gláucia E. Callera, et al.. (2011). Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. Journal of the American Society of Hypertension. 5(3). 137–153. 77 indexed citations
13.
Tabet, Fatiha, Alan T. Remaley, Aude I. Ségaliny, et al.. (2009). The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro. Arteriosclerosis Thrombosis and Vascular Biology. 30(2). 246–252. 99 indexed citations
14.
Tabet, Fatiha & Kerry‐Anne Rye. (2008). High-density lipoproteins, inflammation and oxidative stress. Clinical Science. 116(2). 87–98. 128 indexed citations
15.
Tabet, Fatiha, Ernesto L. Schiffrin, Gláucia E. Callera, et al.. (2008). Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR. Circulation Research. 103(2). 149–158. 86 indexed citations
17.
Tabet, Fatiha, Carmine Savoia, Ernesto L. Schiffrin, & Rhian M. Touyz. (2004). Differential Calcium Regulation by Hydrogen Peroxide and Superoxide in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology. 44(2). 200–208. 111 indexed citations
18.
Touyz, Rhian M., et al.. (2003). Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Canadian Journal of Physiology and Pharmacology. 81(2). 159–167. 78 indexed citations
19.
Touyz, Rhian M., Fatiha Tabet, & Ernesto L. Schiffrin. (2003). Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension. Clinical and Experimental Pharmacology and Physiology. 30(11). 860–866. 180 indexed citations
20.
Schlesinger, Paul H., et al.. (1977). The Treatment of Hypertension with Indapamide: A Controlled Trial. Current Medical Research and Opinion. 5(sup1). 159–164. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026